 DAHANCA receives pharmaceutical industry sponsorship in order to conduct these trials, but it is an independent body, and industry bodies do not have the ability to exert their influence to suppress negative results.The most recent study was DAHANCA 10 in 2007.DAHANCA 10 was a multicenter, double-blind, randomized, placebo-controlled study on darbepoetin-α (Aranesp, Amgen).